ESPERION THERAPEUTICS INC (ESPR) Earnings History & Surprises
NASDAQ:ESPR • US29664W1053
2.72 USD
-0.05 (-1.81%)
At close: Mar 6, 2026
2.73 USD
+0.01 (+0.37%)
After Hours: 3/6/2026, 8:14:28 PM
Past quarterly earnings results for ESPERION THERAPEUTICS INC (ESPR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMar 10, 2026
PeriodQ4 / 2025
EPS Estimate$0.26
Revenue Estimate182.2M
Last Reported
Release DateNov 6, 2025
PeriodQ3 / 2025
EPS Reported-$0.16
EPS Surprise -183.71%
Revenue Surprise 10.02%
Beat Rate
69%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.16 | -0.06 | -183.71% | -6.67% | 87.309M | 79.359M | 10.02% | 69.10% |
| Q2 2025 | -0.02 | -0.15 | 86.52% | 93.94% | 82.385M | 64.31M | 28.11% | 11.58% |
| Q1 2025 | -0.21 | -0.16 | -32.97% | -161.76% | 64.995M | 55.425M | 17.27% | -52.81% |
| Q4 2024 | -0.11 | -0.15 | 27.50% | 78.00% | 69.113M | 62.817M | 10.02% | 114.30% |
| Q3 2024 | -0.15 | -0.18 | 16.24% | 59.46% | 51.632M | 52.348M | -1.37% | 52.00% |
| Q2 2024 | -0.33 | -0.19 | -75.67% | 28.26% | 73.834M | 48.443M | 52.41% | 186.33% |
| Q1 2024 | 0.34 | 0.05 | 613.01% | 143.04% | 137.735M | 85.373M | 61.33% | 466.14% |
| Q4 2023 | -0.50 | -0.49 | -1.60% | 34.21% | 32.25M | 29.271M | 10.18% | 71.54% |
| Q3 2023 | -0.37 | -0.44 | 16.08% | 54.32% | 33.969M | 30.175M | 12.57% | 78.78% |
| Q2 2023 | -0.46 | -0.62 | 26.23% | 56.19% | 25.786M | 25.13M | 2.61% | 37.16% |
| Q1 2023 | -0.79 | -0.67 | -18.72% | 15.05% | 24.329M | 22.452M | 8.36% | 29.41% |
| Q4 2022 | -0.76 | -0.86 | 11.37% | 57.06% | 18.8M | 21.264M | -11.59% | 22.08% |
| Q3 2022 | -0.81 | -0.94 | 14.09% | 69.08% | 19M | 20.313M | -6.46% | 31.94% |
| Q2 2022 | -1.05 | -0.94 | -11.17% | 37.13% | 18.8M | 19.083M | -1.48% | -53.81% |
| Q1 2022 | -0.93 | -1.06 | 12.63% | 73.43% | 18.8M | 15.695M | 19.78% | 135.00% |
| Q4 2021 | -1.77 | -2.32 | 23.55% | 54.50% | 15.4M | 14.771M | 4.26% | 60.42% |
| Q3 2021 | -2.62 | -2.86 | 8.41% | 14.66% | 14.4M | 12.126M | 18.75% | 278.95% |
| Q2 2021 | -1.67 | -1.88 | 11.15% | -138.66% | 40.7M | 43.028M | -5.41% | -80.82% |
| Q1 2021 | -3.50 | -2.57 | -36.35% | -23.24% | 8M | 22.475M | -64.40% | 344.44% |
| Q4 2020 | -3.89 | -3.84 | -1.43% | - | 9.6M | 12.766M | -24.80% | - |
| Q3 2020 | -3.07 | -3.50 | 12.41% | - | 3.8M | 5.273M | -27.93% | - |
| Q2 2020 | 4.32 | 1.74 | 148.23% | - | 212.2M | 150.93M | 40.59% | - |
| Q1 2020 | -2.84 | -3.36 | 15.51% | - | 1.8M | 528.87K | 240.35% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-25.67%
Max EPS beat (4)
86.52%
Min EPS beat (4)
-183.71%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
16.35%
Max Revenue beat (4)
28.11%
Min Revenue beat (4)
10.02%
Analysis
In the last 4 quarters, ESPR has beaten EPS estimates in 2 out of 4 releases
ESPR has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, ESPR reported -25.7% below the EPS estimates on average.
In the last 4 quarters, ESPR has beaten the revenue estimates by 16.4% on average.
ESPERION THERAPEUTICS INC / ESPR Earnings FAQ
When did ESPERION THERAPEUTICS INC (ESPR) report earnings last quarter?
ESPERION THERAPEUTICS INC (ESPR) last reported earnings on 11/6/2025.
Did ESPR stock beat earnings estimates in the most recent quarter?
ESPERION THERAPEUTICS INC (ESPR) missed EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often ESPERION THERAPEUTICS INC beats earnings estimates?
In the last 4 quarters, ESPERION THERAPEUTICS INC (ESPR) has beaten EPS estimates in 2 out of 4 releases.